Neurophth Therapeutics Funding: $125M Raised, Series C+
Neurophth Therapeutics has raised $125M in total funding. Latest round: Series C+.
Neurophth Therapeutics funding overview
Neurophth Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C+ announced in April 2020. The round record for Neurophth Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Fosun's InnoStar Venture, Sequoia Capital China, CMG-SDIC Capital, Yangtze River Industry Fund, Wuhan Optical Valley Financial Holding Group, Wuhan Hi-Tech Holding Group and 1 others. 7 distinct backers are named across the disclosed rounds.
Neurophth Therapeutics at a glance
Total raised
$125M
Latest round
Series C+
Latest round date
April 2020
Notable investors
Fosun's InnoStar Venture, Sequoia Capital China, CMG-SDIC Capital, Yangtze River Industry Fund, Wuhan Optical Valley Financial Holding Group, Wuhan Hi-Tech Holding Group, Sunshine Insurance
Frequently asked about Neurophth Therapeutics funding
How much has Neurophth Therapeutics raised?
Neurophth Therapeutics has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Neurophth Therapeutics?
Fosun's InnoStar Venture, Sequoia Capital China, CMG-SDIC Capital, Yangtze River Industry Fund, Wuhan Optical Valley Financial Holding Group, Wuhan Hi-Tech Holding Group are named among the investors backing Neurophth Therapeutics.
What was the latest Neurophth Therapeutics funding round?
The most recent disclosed round is a Series C+, announced in April 2020.
Where is Neurophth Therapeutics based?
No headquarters location is disclosed for Neurophth Therapeutics.
When did Neurophth Therapeutics last raise?
The last disclosed Neurophth Therapeutics round closed in April 2020 at Series C+.
Round data for Neurophth Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
